Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With Lenvatinib.

differentiated thyroid carcinoma lenvatinib radioiodine-refractory differentiated thyroid cancer thyroglobulin autoantibodies

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
03 Jul 2023
Historique:
received: 13 04 2023
medline: 13 7 2023
pubmed: 13 7 2023
entrez: 13 7 2023
Statut: epublish

Résumé

Serum thyroglobulin (Tg) is a highly sensitive and specific tumor marker, employed in post-operative management of patients with differentiated thyroid carcinomas. Tumor shrinkage of radioiodine-refractory thyroid cancer (RAIR-DTC) treated with multitarget kinase inhibitors as lenvatinib, expressed according to the Response Evaluation Criteria in Solid Tumors (RECIST), is also associated with a drastic reduction of Tg levels. However, interference caused by circulating thyroglobulin autoantibodies (TgAb) represents the main limitation in the clinical use of Tg. To evaluate if in RAIR-DTC TgAb could be considered a surrogate marker of Tg in monitoring response to treatment with lenvatinib. We retrospectively evaluated patients who had started lenvatinib and correlated serum Tg and TgAb with the radiological response across visits. University of Pisa, Italy. We selected 9/97 RAIR-DTC patients with detectable TgAb. None. None. Tg values correlated neither with TgAb title nor with radiological response across visits. Greater decreases in TgAb titer correlated with favorable radiological response to lenvatinib after 1 month (Spearman's correlation = 0.74, TgAb evaluation may represent a reliable surrogate marker for Tg trend in evaluating response of RAIR-DTC to treatment with lenvatinib. A multicentric study would be useful to confirm our results.

Identifiants

pubmed: 37440964
doi: 10.1210/jendso/bvad084
pii: bvad084
pmc: PMC10334479
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bvad084

Informations de copyright

Published by Oxford University Press on behalf of the Endocrine Society 2023.

Références

Clin Endocrinol (Oxf). 1980 Jan;12(1):29-38
pubmed: 6892894
Expert Opin Pharmacother. 2016 Aug;17(12):1683-91
pubmed: 27398740
Int J Endocrinol. 2022 Mar 10;2022:7173919
pubmed: 35311033
Thyroid. 2000 May;10(5):431-3
pubmed: 10884191
Thyroid. 2018 Mar;28(3):288-294
pubmed: 29439614
J Clin Endocrinol Metab. 1995 Feb;80(2):468-72
pubmed: 7852506
Immunity. 1998 Mar;8(3):363-72
pubmed: 9529153
Lancet. 2014 Jul 26;384(9940):319-28
pubmed: 24768112
Nat Commun. 2017 Nov 24;8(1):1781
pubmed: 29176567
J Clin Endocrinol Metab. 2008 Dec;93(12):4683-9
pubmed: 18812478
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Endocr J. 2017 Aug 30;64(8):819-826
pubmed: 28659544
Thyroid. 2011 Jul;21(7):707-16
pubmed: 21649472
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Oncogene. 2001 Apr 26;20(18):2281-90
pubmed: 11402323
Cancer. 2017 Feb 1;123(3):372-381
pubmed: 27741354
Ann Intern Med. 2003 Sep 2;139(5 Pt 1):346-51
pubmed: 12965943
Endocrinol Metab Clin North Am. 1995 Dec;24(4):841-63
pubmed: 8608781
Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):223-33
pubmed: 18268520
Curr Opin Endocrinol Diabetes Obes. 2014 Oct;21(5):394-404
pubmed: 25122493
Eur J Endocrinol. 2005 Jul;153(1):49-55
pubmed: 15994745
Clin Endocrinol (Oxf). 2003 Feb;58(2):138-40
pubmed: 12580927
Eur J Endocrinol. 2006 Jun;154(6):787-803
pubmed: 16728537
Clin Chim Acta. 1982 Aug 18;123(3):347-55
pubmed: 7116651
Allergy. 1982 Apr;37(3):161-7
pubmed: 6127965
N Engl J Med. 2015 Feb 12;372(7):621-30
pubmed: 25671254
J Clin Endocrinol Metab. 2011 Dec;96(12):3615-27
pubmed: 21917876
Sci Rep. 2016 Jun 16;6:28081
pubmed: 27306607
J Clin Endocrinol Metab. 1998 Apr;83(4):1121-7
pubmed: 9543128
J Clin Endocrinol Metab. 2011 May;96(5):1283-91
pubmed: 21325460
Thyroid. 2002 Aug;12(8):707-11
pubmed: 12225639
J Clin Endocrinol Metab. 2002 Feb;87(2):489-99
pubmed: 11836274
Thyroid. 2018 Jul;28(7):871-879
pubmed: 29860933
J Clin Endocrinol Metab. 2012 Nov;97(11):3974-82
pubmed: 22948755
Thyroid. 2016 Jun;26(6):798-806
pubmed: 27020734

Auteurs

Daniele Sgrò (D)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Piercarlo Rossi (P)

Radiology, Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa 56127, Italy.

Paolo Piaggi (P)

Department of Information Engineering, University of Pisa, Pisa 56127, Italy.

Alessandro Brancatella (A)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Loredana Lorusso (L)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Valeria Bottici (V)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Eleonora Molinaro (E)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Francesco Latrofa (F)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Rossella Elisei (R)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Laura Agate (L)

Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56127, Italy.

Classifications MeSH